Cargando…
Use of dabigatran for treatment of left ventricular thrombus: A tertiary care center experience
OBJECTIVES: Direct oral anticoagulants (DOACs) are now replacing vitamin K oral anticoagulants (VKAs) owing to superior efficacy, rapid action, less bleeding, wider therapeutic range,and fewer food and drug interactions.Unfortunately, the available data on the use of DOACs, particularly dabigatran,...
Autores principales: | Verma, Bhupendra, Singh, Amrita, Kumar, Manu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753807/ https://www.ncbi.nlm.nih.gov/pubmed/31548950 http://dx.doi.org/10.4103/jfmpc.jfmpc_459_19 |
Ejemplares similares
-
Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013) -
Dabigatran Effect on Left Ventricular Thrombus in a Patient with Acute Ischemic Stroke
por: Chung, Kyuyoon, et al.
Publicado: (2015) -
Thrombus Formation in Left Atrium on Dabigatran Therapy
por: Shah, Priyank, et al.
Publicado: (2015) -
Large Left Ventricular Thrombus as a Cause of Recurrent Cardioembolic Stroke While on Dabigatran
por: Moey, Melissa Y.Y., et al.
Publicado: (2018) -
Left atrial appendage thrombus on full-dose dabigatran treatment: a case report
por: Candelaresi, Paolo, et al.
Publicado: (2020)